Company Filing History:
1 out of 647 
1 out of 203 
1 out of 1 Years Active: 2015-2023
Title: Innovations by Andrew Douglas Penman
Introduction
Andrew Douglas Penman is an accomplished inventor based in Birmingham, AL (US). He holds a total of 2 patents that showcase his contributions to the field of medical technology. His work primarily focuses on developing advanced diagnostic tools and engineered tissue constructs.
Latest Patents
One of his latest patents is a point-of-care apparatus and methods for detecting cancer using electrochemical impedance or capacitance spectroscopy. This innovative device allows for the detection of biomarkers or other analytes in bodily fluids through Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (ECS). The technology utilizes a working electrode with an antibody or other target-capturing molecule, enabling precise measurements through imaginary impedance or phase shift.
Another significant patent involves three-dimensional, prevascularized, engineered tissue constructs. This patent details the creation of 3D prevascularized engineered tissue models of cancer, along with bioreactors and bioreactor arrays that incorporate these tissue constructs. The methods outlined in this patent facilitate drug discovery and cancer research, providing valuable tools for scientists and medical professionals.
Career Highlights
Throughout his career, Andrew has worked with notable organizations such as the UAB Research Foundation and Southern Research Institute. His experience in these institutions has allowed him to contribute significantly to research and development in the medical field.
Collaborations
Andrew has collaborated with esteemed colleagues, including Joel L. Berry and Timothy M. Wick. Their combined expertise has further advanced the projects they have worked on together.
Conclusion
Andrew Douglas Penman is a notable inventor whose work in medical technology has the potential to revolutionize cancer detection and treatment. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.